TrialJournal of translational medicine2023

Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results.

Marc Gotkine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.